Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	56.04	72.73	46.61
Graham Fair Price	33.34	57.44	43.08
PEG	-58.11	0.45	-1.07
Price/Book	1.82	2.17	2.13
Price/Cash Flow	201.54	-184.69	61.25
Prices/Earnings	-43.45	35.73	63.19
Price/Sales	3.79	7.76	7.48
Price/FCF	201.54	-184.69	61.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-16.05	0.22	0.26
Operating Margin	-23.10	0.08	0.10
ROA	78.56	< 0.005	< 0.005
ROE	< 0.005	0.02	80.06
ROIC	0.03	0.01	-56.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.02	23.11
Dividends QOQ	< 0.005	0.04	2171.68
EBIT QOQ	< 0.005	-0.25	-6874.96
EPS QOQ	-0.59	0.80	34.98
FCF QOQ	0.65	-1.34	105.32
Revenue QOQ	0.09	-0.02	-72.06
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	33.67	32.72	-2.82
Days Sales Outstanding (DSO)	74.60	81.36	9.07
Inventory Turnover	2.67	2.75	2.90
Debt/Capitalization	0.41	0.42	3.45
Quick Ratio	0.62	0.61	-1.29
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	98.97	98.35	-0.63
Cash	2.95	2.51	-14.91
Capex	-0.72	-0.61	16.15
Free Cash Flow	3.44	-1.15	-66.45
Revenue	28.16	27.46	-2.52
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.99	0.96	-2.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.70	17.93	53.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating